Filed: 5/15/2026ACC: 0000950142-26-001406
📋 What this filing means
GENERAL ATLANTIC, L.P. filed this quarterly 13F‑HR report disclosing 12 equity positions with a total reported market value of $2.15B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
12
Positions
$2.15B
Total AUM (reported)
138.98M
Total Shares
Allocation by class
CL A$1.49B69.6%
COM$599.63M27.9%
ADS$53.81M2.5%
ORD SHS$243.9K0.0%
Portfolio Concentration
Top 3$1.39B64.9%
4–10$750.10M34.9%
11–25$3.41M0.2%
Top 3 weight
64.9%
Top 10 weight
99.8%
Voting Authority Distribution
Total shares with voting rights: 138.98M
Sole
Full voting authority
138.98M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole12
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings12
Rows:
DLOCAL
SOLEShares46.66M
TypeSH
Market value$605.14M
28.17%
Sole
46.66M
Shared
0.00
None
0.00
CHIME
SOLEShares21.26M
TypeSH
Market value$398.19M
18.53%
Sole
21.26M
Shared
0.00
None
0.00
XP, INC
SOLEShares20.57M
TypeSH
Market value$391.58M
18.23%
Sole
20.57M
Shared
0.00
None
0.00
ALKAMI
SOLEShares15.34M
TypeSH
Market value$240.34M
11.19%
Sole
15.34M
Shared
0.00
None
0.00
PHARVARIS
SOLEShares8.03M
TypeSH
Market value$226.88M
10.56%
Sole
8.03M
Shared
0.00
None
0.00
EUROPEAN WAX CENTER
SOLEShares13.11M
TypeSH
Market value$75.78M
3.53%
Sole
13.11M
Shared
0.00
None
0.00
REVOLUTION MEDICINES
SOLEShares707.79K
TypeSH
Market value$68.83M
3.20%
Sole
707.79K
Shared
0.00
None
0.00
NURIX THERAPEUTICS
SOLEShares4.10M
TypeSH
Market value$63.58M
2.96%
Sole
4.10M
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS
SOLEShares1.35M
TypeSH
Market value$53.81M
2.50%
Sole
1.35M
Shared
0.00
None
0.00
RISKIFIED
SOLEShares5.32M
TypeSH
Market value$20.87M
0.97%
Sole
5.32M
Shared
0.00
None
0.00
GROVE COLLABORATIVE
SOLEShares2.47M
TypeSH
Market value$3.17M
0.15%
Sole
2.47M
Shared
0.00
None
0.00
WEBULL
SOLEShares50.82K
TypeSH
Market value$243.9K
0.01%
Sole
50.82K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
DLOCALSOLE | CL A | 46.66M | SH | $605.14M 28.17% | 46.66M | 0.00 | 0.00 |
CHIMESOLE | CL A | 21.26M | SH | $398.19M 18.53% | 21.26M | 0.00 | 0.00 |
XP, INCSOLE | CL A | 20.57M | SH | $391.58M 18.23% | 20.57M | 0.00 | 0.00 |
ALKAMISOLE | COM | 15.34M | SH | $240.34M 11.19% | 15.34M | 0.00 | 0.00 |
PHARVARISSOLE | COM | 8.03M | SH | $226.88M 10.56% | 8.03M | 0.00 | 0.00 |
EUROPEAN WAX CENTERSOLE | CL A | 13.11M | SH | $75.78M 3.53% | 13.11M | 0.00 | 0.00 |
REVOLUTION MEDICINESSOLE | COM | 707.79K | SH | $68.83M 3.20% | 707.79K | 0.00 | 0.00 |
NURIX THERAPEUTICSSOLE | COM | 4.10M | SH | $63.58M 2.96% | 4.10M | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALSSOLE | ADS | 1.35M | SH | $53.81M 2.50% | 1.35M | 0.00 | 0.00 |
RISKIFIEDSOLE | CL A | 5.32M | SH | $20.87M 0.97% | 5.32M | 0.00 | 0.00 |
GROVE COLLABORATIVESOLE | CL A | 2.47M | SH | $3.17M 0.15% | 2.47M | 0.00 | 0.00 |
WEBULLSOLE | ORD SHS | 50.82K | SH | $243.9K 0.01% | 50.82K | 0.00 | 0.00 |